EZH2 and adrenal cortex carcinoma: High expression of EZH2 was also a significant risk factor for DFS in patients with ACC, BLCA, KICH, kidney renal papillary cell carcinoma (KIRP), LGG, LIHC, PRAD, and THCA (Figure 8B).